06/04/2025
3:05 PM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
10:46 AM | Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
10:44 AM | Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2025
12:19 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
3:42 PM | Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
| Form SCHEDULE 13G | |
05/12/2025
1:22 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025
6:01 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
6:33 AM | Apellis Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2025
6:35 AM | Apellis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2025
6:36 AM | Apellis Pharmaceuticals (Filer)
| Form ARS | |
04/21/2025
3:23 PM | Apellis Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for APLS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/21/2025
6:11 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
11:27 AM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
2:18 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
6:22 AM | Apellis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
6:00 AM | Apellis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
12:59 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
2:13 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025
9:49 AM | Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
12:09 PM | Apellis Pharmaceuticals (Subject)
MORGAN STANLEY (Filed by)
| Form SCHEDULE 13G | |
01/30/2025
11:13 AM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:15 AM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:18 AM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:20 AM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:01 AM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:03 AM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:07 AM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:10 AM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
11:12 AM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
2:42 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:18 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:22 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:26 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:11 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:12 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:16 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:16 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
2:17 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
2:37 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:39 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:41 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad) Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.”
We recently sat down with Rickards to capture all the key details on tape.
 For the moment, you can watch this interview free of charge – just click here. |
01/23/2025
2:23 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:25 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:26 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:28 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:29 PM | Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:31 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
2:19 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:00 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:39 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:42 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:43 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:44 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:45 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:45 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:51 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:52 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
2:56 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
2:56 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
2:59 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
2:54 PM | Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
3:38 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:20 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:27 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:29 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
3:22 PM | Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:25 PM | Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:29 PM | Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:30 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:09 PM | Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:10 PM | Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:14 PM | Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:15 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:55 PM | Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
4:56 PM | Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:00 PM | Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:02 PM | Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:02 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:05 PM | Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:07 PM | Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:09 PM | Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:13 PM | Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:15 PM | Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
8:08 AM | Apellis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:38 PM | Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/10/2025
4:39 PM | Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:03 PM | Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
2:17 PM | Apellis Pharmaceuticals (Subject)
Baumal Caroline (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
3:06 PM | Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
3:48 PM | Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Utah’s New Oil Find (Ad) The Real Reason 218,000 Acres Just Vanished
The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake. Find out why this could be the most lucrative "underground" energy story in America |
11/22/2024
3:16 PM | Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/22/2024
7:47 AM | Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G | |
11/08/2024
4:31 PM | Apellis Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
11/08/2024
9:52 AM | Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/05/2024
5:57 AM | Apellis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
5:43 PM | Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:15 PM | Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
3:20 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:21 PM | Apellis Pharmaceuticals (Issuer)
Dunlop A. Sinclair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
